Section: Application Domains

Pharmacovigilance

In pharmacovigilance, the goal is to detect, as soon as possible, potential associations between certain drugs and adverse effects, which appeared after the authorized marketing of these drugs. Preceding works showed the importance of defining an adapted methodology to deal with the size of the individual data (around 250000 reports, 2000 drugs, 4000 adverse effects) and their sparsity. We will explore several aspects from software point of view to statistical strategies as sub-sampling.